SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Residential Real Estate Crash Index
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: NOW who wrote (198229)4/25/2009 8:29:30 PM
From: Think4YourselfRead Replies (2) of 306849
 
The makers of the antivirals will profit but only because these are the only antivirals known to man to be effective. Other than that I am not sure what your question is. If you are questioning if they work, the answer is simple. If the patients who get them recover quicker, or don't die, then they work. They already know Tamiflu appears to be effective in this outbreak but, once again, the drug has to be taken early in the stage of infection. If you wait until it's full blown flu, the drug rarely works because of the sheer quantity of virus and how fast they multiply. It's a statistics and probability game involving genetic mutation.

Over time the successful virus's in the environment adapt to the drugs, which is why Relenza (an older drug) often doesn't work. Eventually Tamiflu also won't work.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News